Related Experiment Video
Updated: Aug 5, 2026
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
An IL-34-IGF-1 inflammatory axis fuels KRAS-mutant lung cancer progression
Biorxiv : the Preprint Server for Biology
|July 29, 2026
Summary
KRAS G12D mutations in lung cancer promote the proliferation of resident alveolar macrophages. These macrophages then fuel tumor cell growth and survival, driving lung cancer progression and indicating new therapeutic targets.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Macrophages are innate immune cells with diverse roles in tissue homeostasis and disease.
- Specific macrophage subsets can be co-opted to promote tumor growth and metastasis.
- Understanding macrophage roles in lung cancer is crucial for developing new therapies.
Purpose of the Study:
- To investigate the role of resident alveolar macrophages in KRAS-driven lung cancer.
- To elucidate the mechanisms by which macrophages promote tumor initiation and progression.
- To identify potential therapeutic targets for lung adenocarcinoma.
Main Methods:
- Utilized genetically engineered mouse models of KRAS G12D non-small cell lung cancer.
- Investigated macrophage proliferation and function in response to tumor-derived factors.
- Assessed the impact of IL-34 neutralization and IGF-1 signaling on tumor progression.
Main Results:
- KRAS G12D mutations drive proliferation of resident alveolar macrophages via IL-34.
- Tumor-associated alveolar macrophages promote tumor cell proliferation through IGF-1.
- IL-34 neutralization reduced macrophage and tumor cell proliferation, inhibiting tumor growth.
- High IL34 and IGF1 expression correlated with poor survival in lung adenocarcinoma patients.
Conclusions:
- Bi-directional signaling between resident macrophages and tumor cells drives lung cancer progression.
- Targeting the IL-34/IGF-1 axis represents a potential therapeutic strategy for KRAS-driven lung cancer.
- Resident macrophage-tumor cell interactions are critical interception points for lung cancer therapy.
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...